AGF Investments Inc’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,101	Closed	-$245K	–	422
2022 Q1	$245K	Sell	10,101 -7,477	-43%	-$181K	﹤0.01%	421
2021 Q4	$410K	Buy	17,578 +6,378	+57%	+$149K	﹤0.01%	494
2021 Q3	$186K	Buy	11,200 +2,664	+31%	+$44.2K	﹤0.01%	567
2021 Q2	$208K	Buy	+8,536	New	+$208K	﹤0.01%	550